GLUTATHIONE S‐TRANSFERASES AND HEPATOCARCINOGENESIS

Japanese Journal of Cancer Research

Volumn 79, Issue 5, 1988, Pages 556-572

  Sato, Kiyomi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE;

LIVER CARCINOGENESIS; NONHUMAN; REVIEW;

ANIMAL; CARCINOGENS; GLUTATHIONE TRANSFERASE; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; PRECANCEROUS CONDITIONS; SUPPORT, NON-U.S. GOV'T;

EID: 0023875771     PISSN: 09105050     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1988.tb00022.x     Document Type: Review

References (122)

1. The sequential analysis of cancer development
2. The sequential analysis of liver cancer induction
3. The stages of initiation and promotion in hepatocarcinogenesis
4. Sequential cellular changes during chemical carcinogenesis
5. Cellular biochemistry of the stepwise development of cancer with chemicals: G. H, A. Clowes memorial lecture
6. Pre‐cancerous steps in carcinogenesis: their physiological adaptive nature
7. Neoplastic progression in experimental hepatocarcinogenesis
8. Cellular events during hepatocarcinogenesis in rats and the question of premalignancy. Adv
9. Expressions of the c‐Ha‐ras and c‐myc genes in rat liver tumors
10. 1‐induced hepatocellular carcinomas
11. 1
12. Molecular forms of glutathione S‐transferase and UDP‐glucuronyltransferase as hepatic preneoplastic marker enzymes
13. Properties of molecular forms of γ‐glutamyl transpeptidase and uridine diphosphate‐glucuronyltransferase as hepatic preneoplastic marker enzymes
14. The biochemistry of preneoplastic liver: a common metabolic pattern in hepatocyte nodules
15. A common biochemical pattern in preneoplastic hepatocyte nodules generated in four different models in the rat
16. Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia
17. Hepatocarcinogenesis in the rat: the effect of promoters and carcinogens in vivo and in vitro
18. Glutathione S‐transferases as markers for preneoplasia
19. The glutathione S‐transferases: a group of multifunctional detoxification proteins
20. The role of glutathione and glutathione‐S‐transferases in the metabolism of chemical carcinogens and other electrophilic agents
21. The isoenzymes of glutathione transferase
22. The placental form of glutathione S‐transferase as a new marker protein for preneoplasia in rat chemical hepatocarcinogenesis
23. Changes in molecular forms of rat hepatic glutathione S‐transferase during chemical hepatocarcinogenesis
24. Purification, induction, and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis
25. Relative merits of immunohistochemical demonstrations of placental, A, B and C forms of glutathione S‐transferase and histochemical demonstration of γ‐glutamyltransferase as markers of altered foci durig liver carcinogenesis in rats
26. Glutathione transferases in primary rat hepatomas: the isolation of a form with GSH peroxidase activity
27. Selective expression of glutathione transferase isoenzymes in chemically induced preneoplastic rat hepatocyte nodules
28. Microsomal glutathione S‐transferase. Purification, initial characterization and demonstration that it is not identical to the cytosolic glutathione S‐transferases A, B and C
29. Membrane‐bound glutathione transferase
30. 4 formation by particulate enzymes
31. 4 synthetase of rat basophil leukemia cells: a novel, particulate glutathione S‐transferase
32. 4 synthetase of rat basophilic leukemia cells
33. Use of immuno‐blot techniques to discriminate between the glutathione S‐transferase Yf, Yk, Ya, Yn/Yb and Yc subunits and to study their distribution in extrahepatic tissues
34. Ligandin heterogeneity: evidence that the two non‐identical subunits are the monomers of two distinct proteins
35. Glutathione transferases: nomenclature
36. Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties
37. Ligandin: a hepatic protein which binds steroids, bilirubin, carcinogens and a number of exogenous organic anions
38. The identity of glutathione S‐transferase B with ligandin, a major binding protein of liver
39. Ligandin, the glutathione S‐transferases, and chemically induced hepatocarcinogenesis: a review
40. Detoxication reactions of glutathione and glutathione transferases
41. Properties of the increased glutathione S‐transferase A form in rat preneoplastic hepatic lesions induced by chemical carcinogens
42. Placental glutathione S‐transferase as a marker for (pre) neoplastic tissues
43. Isoenzymes of glutathione transferase in rat kidney cytosol
44. Glutathione transferase in rat lung: the presence of transferase 7‐7, highly efficient in the conjugation of glutathione with the carcinogenic (+)‐7β,8α‐dihydroxy‐9α, 10α‐oxy ‐ 7, 8, 9, 10‐tetrahydrobenzo[α]pyrene
45. Natural distribution of placental glutathione S‐transferase and its modulation by chemicals
46. 4 synthase activity from rat brain
47. A new principle for the analysis of chemical carcinogenesis
48. Identification of the placental form of glutathione S‐transferase as a new marker protein for preneoplasia in rat chemical hepatocarcinogenesis
49. Changes in polypeptide pattern of rat liver cells during chemical hepatocarcinogenesis
50. The polypeptides of the cytosol of hepatocyte nodules may exhibit a unique electrophoretic pattern
51. A characteristic electrophoretic pattern of cytosolic polypeptides from hepatocyte nodules generated during liver carcinogenesis in several models
52. Identification of P‐21 polypeptide from rat hepatocyte nodule as placental glutathione S‐transferase
53. Identification of a characteristic cytosolic polypeptide of rat preneoplastic hepatocyte nodules as placental glutathione S‐transferase
54. The unlabeled antibody enzyme method of immunohistochemistry. Preparation and properties of soluble antigen‐antibody complex (horseradish peroxidase‐antihorseradish peroxidase) and its use in identification of spirochetes
55. Use of avidin‐biotin‐peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures
56. Placental glutathione S‐transferase (GST‐P) as a new marker for hepatocarcinogenesisi in vivo short‐term screening for hepatocarcinogens
57. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens
58. Sequential histologic study of rat liver during peroxisome proliferator [4‐chloro‐6‐ (2,3 ‐xylidino)‐2‐pyrimidinylthio] ‐acetic acid (Wy‐14,643)‐induced carcinogenesis
59. Hepatic foci of cellular and enzymatic alteration and nodules in rats treated with clofibrate or diethylnitrosamine followed by phenobarbital: their rate of onset and their reversibility
60. Peroxisome proliferator‐induced hepatocarcinogenesis: histochemical analysis of ciprofibrate‐induced preneoplastic and neoplastic lesions for γ‐glutamyl transpeptidase activity
61. Analysis of peroxisome proliferator‐induced preneoplastic and neoplastic lesions of rat liver for placental form of glutathione S‐transferase and γ‐glutamyltranspeptidase
62. Coordinate polypeptide expression during hepatocarcinogenesis in male F‐344 rats: comparison of the Solt‐Farber and Reddy models
63. Induction of altered hepatic foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine
64. Quantitative stereological evaluation of four histochemical markers of altered foci in multistage hepatocarcinogenesis in the rat
65. Comparative effects of carcinogens on the induction of placental glutathione S‐transferase‐positive liver nodules in a short‐term assay and of hepatocellular carcinomas in a long‐term assay
66. Immunohistochemically demonstrated glucose‐6‐phosphate dehydrogenase, γ‐glutamyl transpeptidase, ornithine decarboxylase and glutathione S‐transferase enzymes: absence of direct correlation with cell proliferation in rat liver putative preneoplastic lesions
67. Single GST‐P positive liver cells—putative initiated hepatocytes
68. Persistent effect of a low dose of preadministered diethylnitrosamine on the induction of enzyme‐altered foci in rat liver
69. Di(2‐ethylhexyl)‐phthalate: lack of initiating activity in the liver of female F‐344 rats
70. Lack of rapid initiating, promoting or sequential syncarcinogenic effects of di(2‐ethylhexyl)phthalate in rat liver Carcinogenesis
71. Lead nitrate induces certain biochemical properties characteristic of hepatocyte nodules
72. Inversion of enantioselectivity in GSH conjugation of 9,10‐dihydrobenzo [α] pyrene 7,8‐oxide in hepatic cytosol of rats following induction of hepatic hyperplastic nodules by chemical carcinogens
73. Identification of 4‐hydroxy‐nonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids
74. Changes in activities of glutathione peroxidase and glutathione reductase during chemical hepatocarcinogenesis in the rat
75. Different deviation patterns of carbohydrate‐metabolizing enzymes in primary rat hepatomas induced by different chemical carcinogens
76. Correlative histochemistry of some enzymes of carbohydrate metabolism in preneoplastic and neoplastic lesions in the rat liver
77. Phenotypic instability in focal and nodular lesions induced in a short term system in the rat liver
78. A protein cross‐reacting immunohistochemically with rat glutathione S‐transferase placental form as a marker for preneoplasia in Syrian hamster pancreatic and hepatocarcinogenesis
79. Immunohistochemical detection of the placental form of glutathione S‐transferase in dysplastic and neoplastic human uterine cervix lesions
80. Developmental and hormonal regulation of the major form of hepatic glutathione S‐transferase in male mice
81. Thymine hydroperoxide, a substrate for rat Se‐dependent glutathione peroxidase and glutathione transferase isoenzymes
82. Structure and regulation of rat glutathione S‐transferase P (GST‐P) gene
83. Cloning and the nucleotide sequence of rat glutathione S‐transferase P cDNA
84. Cloning of a cDNA encoding the rat placental glutathione S‐transferase: overproduction of the mRNA in hepatocellular carcinomas
85. Tissue distribution of rat glutathione transferase subunit 7, a hepatoma marker
86. Tissue expression of glutathione transferase subunit 7: a possible multigene family
87. Molecular biology of glutathione transferases
88. The structure of the rat glutathione S‐transferase P gene and related pseudogenes
89. Localization of the gene for glutathione S‐transferase P on rat chromosome 1 at band q43
90. Structural analysis of a rat liver glutathione S‐transferase Ya gene
91. Regulation of genes encoding glutathione S‐transferases in normal and pre‐neoplastic liver
92. Expression of genes encoding glutathione S‐transferases in normal and preneoplastic liver
93. The rat glutathione S‐transferases supergene family: molecular basis of gene multiplicity
94. The Yc and Ya subunits of rat liver glutathione S‐transferases are the products of separate genes
95. Comparative histochemical investigation of the glutathione S‐transferase placental form and γ‐glutamyltranspeptidase during N‐nitrosobis(2‐hydroxypropyl)‐amine‐induced pancreatic Carcinogenesis in hamsters
96. Intestinal metaplasia and altered enzyme expression in propylnitrosamine‐induced Syrian hamster cholangiocellular and gallbladder lesions
97. Altered enzyme expression in propylnitrosamine‐induced Syrian hamster lung lesions
98. Altered drug metabolizing potential of acinar cell lesions induced in rat pancreas by hydroxyaminoquinoline 1‐oxide
99. Glutathione S‐transferase (transferase π) from human placenta is identical or closely related to glutathione S‐transferase (transferase ρ) from erythrocytes
100. Purification and subunit‐structural and immunological characterization of five glutathione S‐transferases in human liver, and the acidic form as a hepatic tumor marker
101. Human placental form of glutathione S‐transferase (GST‐π) as a new immunohistochemical marker for human colonic carcinoma
102. Oncofetal expression of glutathione S‐transferase placental form in human stomach carcinomas
103. Structure and expression of a human class pi glutathione S‐transferase (GST‐π) messenger RNA
104. Phenotypic instability in focal and nodular lesions induced in a short term system in the rat liver
105. The quantitative analysis and stability of histochemical markers of altered hepatic foci in rat liver following initiation by diethylnitrosamine administration and promotion with phenobarbital
106. Stable phenotypic expression of glutathione S‐transferase placental type and unstable phenotypic expression of γ‐glutamyltransferase in rat liver preneoplastic and neoplastic lesions
107. Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S‐transferase‐P form positive foci in rats. An approach for a new medium‐term bioassay system
108. Sexual difference in the histochemical characteristics of “altered cell foci” in the liver of aged Fischer 344 rats
109. Spontaneous occurrence of placental glutathione S‐transferase‐positive foci in the livers of LEC rats
110. Transformation related expression of glutathione‐S‐trans‐ferase P in rat liver cells
111. Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen‐induced resistance to xenobiotics in rats
112. The role of glutathione in determining the response of normal and tumour cells to anti‐cancer drugs
113. Expression of the multidrug‐resistant gene in hepatocarcinogenesis and regenerating rat liver
114. Carcinogen‐induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas
115. Purification of γ‐glutamyl‐transferases from rat hepatomas and hyperplastic hepatic nodules, and comparison with the enzyme from rat kidney